Ing Groep Nv Moderna, Inc. Transaction History

Ing Groep Nv

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 27, 2023	SELL	$96.41 - $126.61 $6.87 Million - $9.02 Million	-71,258 Reduced 96.04%	2,936 $303,000
Q2 2023 Aug 07, 2023	BUY	$118.5 - $160.53 $3.07 Million - $4.16 Million	25,894 Added 53.61%	74,194 $9.01 Million
Q1 2023 May 09, 2023	BUY	$135.66 - $197.02 $6.55 Million - $9.52 Million	48,300 New	48,300 $7.42 Million
Q2 2022 Aug 08, 2022	SELL	$117.13 - $176.59 $1.42 Million - $2.15 Million	-12,148 Reduced 15.31%	67,222 $9.6 Million
Q1 2022 May 13, 2022	BUY	$126.46 - $235.05 $2.04 Million - $3.79 Million	16,106 Added 25.46%	79,370 $13.7 Million
Q4 2021 Feb 11, 2022	BUY	$225.82 - $368.51 $6.02 Million - $9.83 Million	26,678 Added 72.92%	63,264 $16.1 Million
Q3 2021 Nov 02, 2021	BUY	$221.9 - $484.47 $6.55 Million - $14.3 Million	29,506 Added 416.75%	36,586 $14.1 Million
Q2 2021 Aug 13, 2021	BUY	$129.91 - $234.98 $919,762 - $1.66 Million	7,080 New	7,080 $1.66 Million

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Ing Groep Nv, based on Form 13F filings with the SEC.

Stay updated on Ing Groep Nv with notifications on news.